FDA Eli Lilly - Search News

Eli Lilly to spend up to $27 billion in new domestic plants

Hosted on MSN · 1h

Eli Lilly to spend up to $27 billion in new domestic plants amid Trump tariff threat

Drugmaker Eli Lilly plans to invest up to $27 billion to build four new pharmaceutical manufacturing sites in the U.S., the company announced Wednesday, a move that comes as President Trump is threatening import tariffs on pharmaceuticals.

FiercePharma · 4h

With $27B plan to build 4 new plants, Eli Lilly doubles down on US drug manufacturing

Over the last few years, as Eli Lilly has revealed a series of manufacturing investments—each one seemingly more lavish than the last—the company’s spree has begged the question: What will they do | At a press conference in Washington,

emjreviews.com · 1h

Eli Lilly plans record $50bn US manufacturing investment

The company's investment will expand its US manufacturing footprint and is the largest investment of its kind in history.

Off-brand weight loss drug makers are suing the FDA

CNN on MSN · 4d

Ozempic and Wegovy are no longer in shortage, FDA says

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

Drug compounders sue FDA over declaration ending Wegovy shortage

Telehealth provider Hims & Hers said it will tell consumers they need to seek “alternative options on the commercial dosing,” but in earnings Monday still forecast higher revenue and profits in 2025.

Quartz on MSN · 19h

Off-brand weight loss drug makers are suing the FDA again

A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another lawsuit against the U.S. Food and Drug Administration (FDA). This time, it’s over the health regulator’s decision to remove semaglutide — the active ingredient in Novo Nordisk’s (NVO) popular Ozempic and Wegovy treatments — from its drug shortage list.

23mon MSN

Eli Lilly to spend $27 billion to expand U.S. manufacturing with four new sites

Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by ...

1h

Eli Lilly to build 4 more manufacturing sites in US

Eli Lilly ( LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the ...

1h

InnovationRx: Eli Lilly Has Stockpiled Nearly $550 Million Of Its Next Obesity Drug

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

4don MSN

FDA says Ozempic shortage is over, chilling boom in off-brand versions

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

1h

FDA approvals decline but drug innovation remains strong even among small sponsors

Approvals last year included rare disease treatments, new oncology drugs, Eli Lilly’s Kisunla, and Mesoblast's Ryoncil.

FOX 10 Phoenix1h

Pharmacy firm cuts prices for popular weight-loss drug again

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients ...

Pharmaceutical Technology6h

Eli Lilly pays $10m upfront for Organovo’s FXR agonist

Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ ...

23hon MSN

Eli Lilly Cuts Price of Weight-Loss Drug Zepbound for Self-Pay Patients

Eli Lilly has lowered the price of its weight-loss drug Zepbound for patients paying out of pocket and introduced two new ...

Hosted on MSN2h

Eli Lilly Plans to Spend $27 Billion on New U.S. Plants

Drugmaker Eli Lilly plans to build four new manufacturing plants in the U.S., a $27 billion investment that the company ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results